Evaluating the off-label use of medications in children

American Journal of Health-System Pharmacy

Volumn 63, Issue 11, 2006, Pages 1062-1065

  Eiland, Lea S ^a,b   Knight, Patrice ^b  

^a AUBURN UNIVERSITY   (United States)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; AMITRIPTYLINE; BUDESONIDE; CAPTOPRIL; CLONIDINE; DEXAMETHASONE; DIPHENHYDRAMINE; GABAPENTIN; HYDROXYUREA; IMMUNOGLOBULIN; IPRATROPIUM BROMIDE; IPRATROPIUM BROMIDE PLUS SALBUTAMOL SULFATE; LABETALOL; LACTULOSE; LEVALBUTEROL; LORAZEPAM; MACROGOL; METHYLPREDNISOLONE; METOCLOPRAMIDE; METRONIDAZOLE; NALBUPHINE; ONDANSETRON; PANTOPRAZOLE; PAROXETINE; PREDNISOLONE; RANITIDINE; SALBUTAMOL; SULTAMICILLIN; UNINDEXED DRUG;

ABDOMINAL INFECTION; ADOLESCENT; ANXIETY DISORDER; APNEA; ASTHMA; ATTENTION DEFICIT DISORDER; BRONCHIOLITIS; CHILD; CHRONIC LUNG DISEASE; COLITIS; CONSTIPATION; CROHN DISEASE; CROUP; DEPRESSION; DIARRHEA; DRUG INDICATION; EVALUATION; FIBROMYALGIA; FOOD AND DRUG ADMINISTRATION; GASTROENTERITIS; GASTROESOPHAGEAL REFLUX; GILLES DE LA TOURETTE SYNDROME; GINGIVITIS; GUILLAIN BARRE SYNDROME; HEART FAILURE; HUMAN; HYPERTENSION; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MANIA; MIGRAINE; MOOD DISORDER; MUCOCUTANEOUS LYMPH NODE SYNDROME; MUSCLE SPASM; NAUSEA; NEUROPATHIC PAIN; NEWBORN; NOTE; OFF LABEL DRUG USE; PAIN; POSTOPERATIVE NAUSEA AND VOMITING; PRESCRIPTION; PRIORITY JOURNAL; RHINITIS; SEDATION; SEIZURE; SICKLE CELL ANEMIA; STRESS ULCER; STROKE; URINARY TRACT INFECTION; VOMITING;

EID: 33744903624     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp050476     Document Type: Note

References (21)

1. American Academy of Pediatrics Committee on Drugs. Uses of drugs not described in the package insert (off-label uses). Pediatrics. 2002; 110:181-3.
2. Meadows M. Drug research and children. FDA Consum. 2003; 37(1):12-7.
3. McQueen KD, Milton JD. Multicenter postmarketing surveillance of ondansetron therapy in pediatric patients. Ann Pharmacother. 1994; 28:85-92.
4. Cubeddu LX, Trujillo LM, Talmaciu I et al. Antiemetic activity of ondansetron in acute gastroenteritis. Aliment Pharmacol Ther. 1997; 11:185-91.
5. Ramsook C, Sahagun-Carreon I, Kozinetz CA et al. A randomized clinical trial comparing oral ondansetron with placebo in children with vomiting from acute gastroenteritis. Ann Emerg Med. 2002; 39:397-403.
6. Reeves JJ, Shannon MW, Fleisher GR. Ondansetron decreases vomiting associated with acute gastroenteritis: a randomized, controlled trial. Pediatrics. 2002; 109:e62.
7. Vaster M, Kost-Byerly S, Maxwell LG. The management of pain in sickle cell disease. Pediatr Clin North Am. 2000; 47:699-710.
8. 'T Jong GW, Eland IA, Sturkenboom MC et al. Determinants for drug prescribing to children below the minimum licensed age. Eur J Clin Pharmacol 2003; 58:701-5.
9. Zerhouni EA. List of drugs for which pediatric studies are needed. Fed Regist. 2004; 68:2789-90.
10. Zerhouni EA. List of drugs for which pediatric studies are needed. Fed Regist. 2004; 68:7243-4.
11. Zerhouni EA. List of drugs for which pediatric studies are needed. Fed Regist. 2004; 69:48402.
12. Zerhouni EA. List of drugs for which pediatric studies are needed. Fed Regist. 2005; 70:3937.
13. Thompson DF, Heflin NR. Frequency and appropriateness of drug prescribing for unlabeled uses in pediatric patients. Am J Hosp Pharm. 1987; 44:792-4.
14. Turner S, Longworth A, Nunn AJ et al. Unlicensed and off label drug use in paediatric wards: prospective study. BMJ. 1998; 316:343-5.
15. Conroy S, McIntyre J, Choonara I. Unlicensed and off label drug use in neonates. Arch Dis Child Fetal Neonatal Ed. 1999; 80:F142-5.
16. Conroy S, McIntyre J. The use of unlicensed and off-label medicines in the neonate. Semin Fetal Neonatal Med. 2005; 10:115-22.
17. 'T Jong GW, Vulto AG, de Hoog M et al. A survey of the use of off-label and unlicensed drugs in a Dutch children's hospital. Pediatrics. 2001; 108:1089-93.
18. McIntyre J, Conroy S, Avery A et al. Unlicensed and off label prescribing of drugs in general practice. Arch Dis Child. 2000; 83:498-501.
19. 'T Jong GW, Eland IA, Sturkenboom MC et al. Unlicensed and off label prescription of drugs to children: population based cohort study. BMJ. 2002; 324:1313-4.
20. Food and Drug Administration. Pediatric exclusivity labeling changes, www.fda. gov/cder/pediatric/labelchange.htm (accessed 2006 Jan 16).
21. Food and Drug Administration. Approved active moieties to which FDA has granted pediatric exclusivity for pediatric studies under section 505A of the Federal Food, Drug, and Cosmetic Act. www. fda.gov/cder/pediatric/exgrant.htm (accessed 2006 Jan 16).